Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Allergan, facing shareholder demands, calls special meeting for Dec. 18
Yahoo/Reuters
Tuesday, August 26, 2014 - 10:23pm
tags:
Allergan, M&A, Valeant Pharmaceuticals
'Black box' warning on antidepressants vastly reduced lawsuits against Eli Lilly, others
Indianpolis Star, IN
Tuesday, August 26, 2014 - 12:38pm
tags:
antidepressants, black box, warnings, Eli Lilly
Novartis CEO Jimenez shrugs off biosimilars in the short term
Fierce Pharma
Tuesday, August 26, 2014 - 12:35pm
tags:
Novartis, Pharma CEOs, Joe Jimenez, biosimilars, Neupogen, Amgen
Does Valeant’s Cost-Cutting Go Too Far?
ProPublica
Tuesday, August 26, 2014 - 11:18am
tags:
FDA, Valeant Pharmaceuticals
CEO says Novo Nordisk not interested in large acquisitions: report
First Word Pharma
Tuesday, August 26, 2014 - 11:15am
tags:
Lars Sorenson, M&A, Novo Nordisk, Pharma CEOs
FDA's 'TurboTax' Pilot Program for Medical Devices Expanding
RAPS.org
Tuesday, August 26, 2014 - 10:26am
tags:
devices, FDA
Generic Drug Makers Tussle With International Standards Group
WSJ Pharmalot
Tuesday, August 26, 2014 - 10:25am
tags:
generics
September Biotech Calendar
TheStreet.com
Tuesday, August 26, 2014 - 10:08am
tags:
Keryx, Orexigen, AstraZeneca, Nektar, Salix, Alimera, Amarin, Merck, EXACT Sciences, NPS Pharmaceuticals
3 Reasons Amgen Inc.'s Stock Could Fall
Motley Fool
Tuesday, August 26, 2014 - 10:00am
tags:
Amgen, Kyprolis
Merck’s Melanoma Drug To Get FDA Approval Earlier Than Expected
Bidness Etc.
Tuesday, August 26, 2014 - 9:47am
tags:
Merck, melanoma, FDA
Sekunjalo, U.S. Co. Partner on Cancer Vaccines: Business Report
Bloomberg
Tuesday, August 26, 2014 - 9:40am
tags:
Sekunjalo, vaccines, cancer, South Africa
New type 2 diabetes treatment Jardiance (empagliflozin) tablets for adults now available in U.S. pharmacies
Yahoo
Tuesday, August 26, 2014 - 9:35am
tags:
Jardiance, diabetes, Boehringer Ingelheim, Eli Lilly
Kite Pharma soars on added evidence that CAR-T treatment quells cancer
Fierce Biotech
Tuesday, August 26, 2014 - 8:32am
tags:
CAR-T, Kite Pharma, KTE-C19, B cell malignancies
Medtronic buys brain stimulation company for $200M
Yahoo/AP
Tuesday, August 26, 2014 - 8:28am
tags:
devices, Medtronic, M&A, Sapiens Steering Brain Stimulation
Pfizer/AstraZeneca: Ready for round 2?
CNBC
Tuesday, August 26, 2014 - 8:24am
tags:
M&A, Pfizer, AstraZeneca
Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Yahoo
Tuesday, August 26, 2014 - 8:23am
tags:
Pfizer, Merck, crizotinib, Pembrolizumab, non-small cell lung cancer, Xalkori
Jumping into global M&A mix key to India growing its pharma industry
Fierce Pharma
Monday, August 25, 2014 - 10:29pm
tags:
India, M&A, Lupin, Ranbaxy, Sun Pharma
Allergan v. Valeant: Here Comes the Lawsuit
Barron's
Monday, August 25, 2014 - 10:22pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
Biotech Company Calithera Wakes Up Sleepy IPO Market
Silicon Beat
Monday, August 25, 2014 - 10:21pm
tags:
IPOs, Calithera, cancer
The 4 Companies Teaming Up For A New Tool To Fight Cancer
Yahoo/Benzinga
Monday, August 25, 2014 - 10:17pm
tags:
cancer, JNJ, Illumina, AstraZeneca, Sanofi, MiSeqDx, DNA sequencing

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.